Clinical and Experimental Metastasis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.7 | Q2 | 61.6% | 1.187 | Q1 | 87.8% |
| 2024 | 3.2 | Q2 | 60.7% | 1.307 | Q1 | 90.0% |
| 2023 | 4.2 | Q2 | 69.4% | 1.216 | Q1 | 89.5% |
| 2022 | 4.0 | Q2 | 61.9% | 1.125 | Q1 | 88.7% |
| 2021 | 4.5 | Q3 | 60.9% | 1.108 | Q1 | 88.6% |
| 2020 | — | — | 1.269 | Q1 | 89.9% | |
| 2019 | — | — | 1.340 | Q1 | 91.0% | |
| 2018 | — | — | 1.229 | Q1 | 88.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF